Browse by Author or Creator

2025

1. Machado, L., Jones, L., Divakar, S., Naidoo, M. and Anthony, K. (2025) A unified model for Duchenne muscular dystrophy gene involvement in cancer: context-dependent tumour suppression and oncogenicity. FEBS Open Bio. 16(1), pp. 222-236. 2211-5463.

2022

1. Naidoo, M., Jones, L., Conboy, B., Hamarneh, W., D'Souza, D., Anthony, K. and Machado, L. (2022) Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma. Poster presented to: Cancer Research UK Brain Tumour Conference, 2022-09-05 - 2022-09-07.
2. Naidoo, M., Jones, L., Conboy, B., Hamarneh, W., D'Souza, D., Anthony, K. and Machado, L. (2022) Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma. Scientific Reports. 12(1) 2045-2322.

2020

1. Jones, L., Naidoo, M., Machado, L. and Anthony, K. (2020) The Duchenne muscular dystrophy gene and cancer. Cellular oncology (Dordrecht). 44(1), pp. 19-32. 2211-3428.

2019

1. Naidoo, M. and Anthony, K. (2019) Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy. Molecular Neurobiology. , pp. 1-20. 0893-7648.